Antinociceptive	O
effect	O
of	O
tebanicline	B:C2699899
for	O
various	O
noxious	O
stimuli	O
-	O
induced	O
behaviours	O
in	O
mice	O
Tebanicline	O
(	O
ABT	O
-	I:C2699899
594	I:C2699899
)	O
,	O
an	O
analogue	O
of	O
epibatidine	O
,	O
exhibits	O
potent	O
antinociceptive	O
effects	O
and	O
high	O
affinity	O
for	O
the	O
nicotinic	O
acetylcholine	I:C0034830
receptor	I:C0034830
in	O
the	O
central	O
nervous	I:C3714787
system	I:C3714787
.	O

Antinociceptive	O
effect	O
of	O
tebanicline	O
for	O
various	O
noxious	O
stimuli	O
-	O
induced	O
behaviours	O
in	O
mice	B:C0025929
Tebanicline	O
(	O
ABT	O
-	I:C2699899
594	I:C2699899
)	O
,	O
an	O
analogue	O
of	O
epibatidine	O
,	O
exhibits	O
potent	O
antinociceptive	O
effects	O
and	O
high	O
affinity	O
for	O
the	O
nicotinic	O
acetylcholine	I:C0034830
receptor	I:C0034830
in	O
the	O
central	O
nervous	I:C3714787
system	I:C3714787
.	O

Antinociceptive	O
effect	O
of	O
tebanicline	O
for	O
various	O
noxious	O
stimuli	O
-	O
induced	O
behaviours	O
in	O
mice	O
Tebanicline	B:C2699899
(	O
ABT	O
-	I:C2699899
594	I:C2699899
)	O
,	O
an	O
analogue	O
of	O
epibatidine	O
,	O
exhibits	O
potent	O
antinociceptive	O
effects	O
and	O
high	O
affinity	O
for	O
the	O
nicotinic	O
acetylcholine	I:C0034830
receptor	I:C0034830
in	O
the	O
central	O
nervous	I:C3714787
system	I:C3714787
.	O

Antinociceptive	O
effect	O
of	O
tebanicline	O
for	O
various	O
noxious	O
stimuli	O
-	O
induced	O
behaviours	O
in	O
mice	O
Tebanicline	O
(	O
ABT	B:C2699899
-	I:C2699899
594	I:C2699899
)	O
,	O
an	O
analogue	O
of	O
epibatidine	O
,	O
exhibits	O
potent	O
antinociceptive	O
effects	O
and	O
high	O
affinity	O
for	O
the	O
nicotinic	O
acetylcholine	I:C0034830
receptor	I:C0034830
in	O
the	O
central	O
nervous	I:C3714787
system	I:C3714787
.	O

Antinociceptive	O
effect	O
of	O
tebanicline	O
for	O
various	O
noxious	O
stimuli	O
-	O
induced	O
behaviours	O
in	O
mice	O
Tebanicline	O
(	O
ABT	O
-	I:C2699899
594	I:C2699899
)	O
,	O
an	O
analogue	O
of	O
epibatidine	B:C0219269
,	O
exhibits	O
potent	O
antinociceptive	O
effects	O
and	O
high	O
affinity	O
for	O
the	O
nicotinic	O
acetylcholine	I:C0034830
receptor	I:C0034830
in	O
the	O
central	O
nervous	I:C3714787
system	I:C3714787
.	O

Antinociceptive	O
effect	O
of	O
tebanicline	O
for	O
various	O
noxious	O
stimuli	O
-	O
induced	O
behaviours	O
in	O
mice	O
Tebanicline	O
(	O
ABT	O
-	I:C2699899
594	I:C2699899
)	O
,	O
an	O
analogue	O
of	O
epibatidine	O
,	O
exhibits	O
potent	O
antinociceptive	O
effects	O
and	O
high	O
affinity	O
for	O
the	O
nicotinic	B:C0034830
acetylcholine	I:C0034830
receptor	I:C0034830
in	O
the	O
central	O
nervous	I:C3714787
system	I:C3714787
.	O

Antinociceptive	O
effect	O
of	O
tebanicline	O
for	O
various	O
noxious	O
stimuli	O
-	O
induced	O
behaviours	O
in	O
mice	O
Tebanicline	O
(	O
ABT	O
-	I:C2699899
594	I:C2699899
)	O
,	O
an	O
analogue	O
of	O
epibatidine	O
,	O
exhibits	O
potent	O
antinociceptive	O
effects	O
and	O
high	O
affinity	O
for	O
the	O
nicotinic	O
acetylcholine	I:C0034830
receptor	I:C0034830
in	O
the	O
central	B:C3714787
nervous	I:C3714787
system	I:C3714787
.	O

We	O
assessed	O
whether	O
tebanicline	B:C2699899
exerts	O
an	O
effect	O
on	O
various	O
noxious	O
stimuli	O
and	O
mediates	O
the	O
nicotine	O
receptor	I:C0597357
or	O
opioid	O
receptor	I:C0034801
through	O
stimulation	O
.	O

We	O
assessed	O
whether	O
tebanicline	O
exerts	O
an	O
effect	O
on	O
various	O
noxious	O
stimuli	O
and	O
mediates	O
the	O
nicotine	B:C0597357
receptor	I:C0597357
or	O
opioid	O
receptor	I:C0034801
through	O
stimulation	O
.	O

We	O
assessed	O
whether	O
tebanicline	O
exerts	O
an	O
effect	O
on	O
various	O
noxious	O
stimuli	O
and	O
mediates	O
the	O
nicotine	O
receptor	I:C0597357
or	O
opioid	B:C0034801
receptor	I:C0034801
through	O
stimulation	O
.	O

We	O
assessed	O
whether	O
tebanicline	O
exerts	O
an	O
effect	O
on	O
various	O
noxious	O
stimuli	O
and	O
mediates	O
the	O
nicotine	O
receptor	I:C0597357
or	O
opioid	O
receptor	I:C0034801
through	O
stimulation	B:C0038337
.	O

The	O
antinociceptive	O
effects	O
of	O
tebanicline	B:C2699899
were	O
determined	O
by	O
noxious	O
chemical	O
,	O
thermal	O
and	O
mechanical	O
stimuli	I:C1155310
-	O
induced	O
behaviours	O
in	O
mice	O
.	O

The	O
antinociceptive	O
effects	O
of	O
tebanicline	O
were	O
determined	O
by	O
noxious	O
chemical	O
,	O
thermal	B:C1621333
and	O
mechanical	O
stimuli	I:C1155310
-	O
induced	O
behaviours	O
in	O
mice	O
.	O

The	O
antinociceptive	O
effects	O
of	O
tebanicline	O
were	O
determined	O
by	O
noxious	O
chemical	O
,	O
thermal	O
and	O
mechanical	B:C1155310
stimuli	I:C1155310
-	O
induced	O
behaviours	O
in	O
mice	O
.	O

The	O
antinociceptive	O
effects	O
of	O
tebanicline	O
were	O
determined	O
by	O
noxious	O
chemical	O
,	O
thermal	O
and	O
mechanical	O
stimuli	I:C1155310
-	O
induced	O
behaviours	O
in	O
mice	B:C0025929
.	O

Tebanicline	B:C2699899
had	O
dose	O
-	O
dependent	O
analgesic	O
effects	I:C0948482
in	O
formalin	O
,	O
hot	O
-	I:C0022885
plate	I:C0022885
and	I:C0022885
tail	I:C0022885
-	I:C0022885
pressure	I:C0022885
tests	I:C0022885
.	O

Tebanicline	O
had	O
dose	O
-	O
dependent	O
analgesic	B:C0948482
effects	I:C0948482
in	O
formalin	O
,	O
hot	O
-	I:C0022885
plate	I:C0022885
and	I:C0022885
tail	I:C0022885
-	I:C0022885
pressure	I:C0022885
tests	I:C0022885
.	O

Tebanicline	O
had	O
dose	O
-	O
dependent	O
analgesic	O
effects	I:C0948482
in	O
formalin	B:C0949307
,	O
hot	O
-	I:C0022885
plate	I:C0022885
and	I:C0022885
tail	I:C0022885
-	I:C0022885
pressure	I:C0022885
tests	I:C0022885
.	O

Tebanicline	O
had	O
dose	O
-	O
dependent	O
analgesic	O
effects	I:C0948482
in	O
formalin	O
,	O
hot	B:C0022885
-	I:C0022885
plate	I:C0022885
and	I:C0022885
tail	I:C0022885
-	I:C0022885
pressure	I:C0022885
tests	I:C0022885
.	O

By	O
contrast	O
,	O
the	O
antinociceptive	O
effect	O
of	O
tebanicline	B:C2699899
was	O
not	O
demonstrated	O
in	O
the	O
tail	O
-	I:C1510438
flick	I:C1510438
assay	I:C1510438
.	O

By	O
contrast	O
,	O
the	O
antinociceptive	O
effect	O
of	O
tebanicline	O
was	O
not	O
demonstrated	O
in	O
the	O
tail	B:C1510438
-	I:C1510438
flick	I:C1510438
assay	I:C1510438
.	O

Pre-treatment	O
with	O
mecamylamine	B:C0025029
,	O
a	O
nicotinic	O
acetylcholine	I:C0242956
receptor	I:C0242956
antagonist	I:C0242956
,	O
blocked	O
the	O
effects	O
of	O
tebanicline	O
in	O
formalin	O
,	O
tail	O
-	I:C0022885
pressure	I:C0022885
and	I:C0022885
hot	I:C0022885
-	I:C0022885
plate	I:C0022885
tests	I:C0022885
.	O

Pre-treatment	O
with	O
mecamylamine	O
,	O
a	O
nicotinic	B:C0242956
acetylcholine	I:C0242956
receptor	I:C0242956
antagonist	I:C0242956
,	O
blocked	O
the	O
effects	O
of	O
tebanicline	O
in	O
formalin	O
,	O
tail	O
-	I:C0022885
pressure	I:C0022885
and	I:C0022885
hot	I:C0022885
-	I:C0022885
plate	I:C0022885
tests	I:C0022885
.	O

Pre-treatment	O
with	O
mecamylamine	O
,	O
a	O
nicotinic	O
acetylcholine	I:C0242956
receptor	I:C0242956
antagonist	I:C0242956
,	O
blocked	O
the	O
effects	O
of	O
tebanicline	B:C2699899
in	O
formalin	O
,	O
tail	O
-	I:C0022885
pressure	I:C0022885
and	I:C0022885
hot	I:C0022885
-	I:C0022885
plate	I:C0022885
tests	I:C0022885
.	O

Pre-treatment	O
with	O
mecamylamine	O
,	O
a	O
nicotinic	O
acetylcholine	I:C0242956
receptor	I:C0242956
antagonist	I:C0242956
,	O
blocked	O
the	O
effects	O
of	O
tebanicline	O
in	O
formalin	B:C0949307
,	O
tail	O
-	I:C0022885
pressure	I:C0022885
and	I:C0022885
hot	I:C0022885
-	I:C0022885
plate	I:C0022885
tests	I:C0022885
.	O

Pre-treatment	O
with	O
mecamylamine	O
,	O
a	O
nicotinic	O
acetylcholine	I:C0242956
receptor	I:C0242956
antagonist	I:C0242956
,	O
blocked	O
the	O
effects	O
of	O
tebanicline	O
in	O
formalin	O
,	O
tail	B:C0022885
-	I:C0022885
pressure	I:C0022885
and	I:C0022885
hot	I:C0022885
-	I:C0022885
plate	I:C0022885
tests	I:C0022885
.	O

Moreover	O
,	O
pre-treatment	O
with	O
naloxone	B:C0027358
,	O
an	O
opioid	O
receptor	I:C3536879
antagonist	I:C3536879
,	O
only	O
partially	O
inhibited	O
the	O
effects	O
of	O
tebanicline	O
in	O
formalin	O
and	O
tail	O
-	I:C0022885
pressure	I:C0022885
tests	I:C0022885
.	O

Moreover	O
,	O
pre-treatment	O
with	O
naloxone	O
,	O
an	O
opioid	B:C3536879
receptor	I:C3536879
antagonist	I:C3536879
,	O
only	O
partially	O
inhibited	O
the	O
effects	O
of	O
tebanicline	O
in	O
formalin	O
and	O
tail	O
-	I:C0022885
pressure	I:C0022885
tests	I:C0022885
.	O

Moreover	O
,	O
pre-treatment	O
with	O
naloxone	O
,	O
an	O
opioid	O
receptor	I:C3536879
antagonist	I:C3536879
,	O
only	O
partially	O
inhibited	O
the	O
effects	O
of	O
tebanicline	B:C2699899
in	O
formalin	O
and	O
tail	O
-	I:C0022885
pressure	I:C0022885
tests	I:C0022885
.	O

Moreover	O
,	O
pre-treatment	O
with	O
naloxone	O
,	O
an	O
opioid	O
receptor	I:C3536879
antagonist	I:C3536879
,	O
only	O
partially	O
inhibited	O
the	O
effects	O
of	O
tebanicline	O
in	O
formalin	B:C0949307
and	O
tail	O
-	I:C0022885
pressure	I:C0022885
tests	I:C0022885
.	O

Moreover	O
,	O
pre-treatment	O
with	O
naloxone	O
,	O
an	O
opioid	O
receptor	I:C3536879
antagonist	I:C3536879
,	O
only	O
partially	O
inhibited	O
the	O
effects	O
of	O
tebanicline	O
in	O
formalin	O
and	O
tail	B:C0022885
-	I:C0022885
pressure	I:C0022885
tests	I:C0022885
.	O

Tebanicline	B:C2699899
produced	O
antinociception	O
in	O
persistent	O
chemical	O
(	O
formalin	O
)	O
,	O
acute	O
thermal	O
(	O
hot	O
-	I:C0022885
plate	I:C0022885
,	O
but	O
not	O
tail	O
-	O
flick	O
)	O
and	O
mechanical	O
(	O
tail	O
-	I:C0022885
pressure	I:C0022885
)	O
pain	O
states	O
.	O

Tebanicline	O
produced	O
antinociception	O
in	O
persistent	O
chemical	B:C0220806
(	O
formalin	O
)	O
,	O
acute	O
thermal	O
(	O
hot	O
-	I:C0022885
plate	I:C0022885
,	O
but	O
not	O
tail	O
-	O
flick	O
)	O
and	O
mechanical	O
(	O
tail	O
-	I:C0022885
pressure	I:C0022885
)	O
pain	O
states	O
.	O

Tebanicline	O
produced	O
antinociception	O
in	O
persistent	O
chemical	O
(	O
formalin	B:C0949307
)	O
,	O
acute	O
thermal	O
(	O
hot	O
-	I:C0022885
plate	I:C0022885
,	O
but	O
not	O
tail	O
-	O
flick	O
)	O
and	O
mechanical	O
(	O
tail	O
-	I:C0022885
pressure	I:C0022885
)	O
pain	O
states	O
.	O

Tebanicline	O
produced	O
antinociception	O
in	O
persistent	O
chemical	O
(	O
formalin	O
)	O
,	O
acute	O
thermal	O
(	O
hot	B:C0022885
-	I:C0022885
plate	I:C0022885
,	O
but	O
not	O
tail	O
-	O
flick	O
)	O
and	O
mechanical	O
(	O
tail	O
-	I:C0022885
pressure	I:C0022885
)	O
pain	O
states	O
.	O

Tebanicline	O
produced	O
antinociception	O
in	O
persistent	O
chemical	O
(	O
formalin	O
)	O
,	O
acute	O
thermal	O
(	O
hot	O
-	I:C0022885
plate	I:C0022885
,	O
but	O
not	O
tail	O
-	O
flick	O
)	O
and	O
mechanical	O
(	O
tail	B:C0022885
-	I:C0022885
pressure	I:C0022885
)	O
pain	O
states	O
.	O

Moreover	O
,	O
tebanicline	B:C2699899
stimulated	O
the	O
nicotinic	O
acetylcholine	I:C0034830
receptor	I:C0034830
and	O
opioid	O
receptor	I:C0034801
.	O

Moreover	O
,	O
tebanicline	O
stimulated	B:C0038337
the	O
nicotinic	O
acetylcholine	I:C0034830
receptor	I:C0034830
and	O
opioid	O
receptor	I:C0034801
.	O

Moreover	O
,	O
tebanicline	O
stimulated	O
the	O
nicotinic	B:C0034830
acetylcholine	I:C0034830
receptor	I:C0034830
and	O
opioid	O
receptor	I:C0034801
.	O

Moreover	O
,	O
tebanicline	O
stimulated	O
the	O
nicotinic	O
acetylcholine	I:C0034830
receptor	I:C0034830
and	O
opioid	B:C0034801
receptor	I:C0034801
.	O

